Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00192309 · ClinicalTrials.gov registry record · Phase 2

Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

A Phase 2 study of Influenza, sponsored by MedImmune.

Completed
Registry status
Phase 2
Development phase
31
Enrollment target
1
Study location

NCT00192309 is a Phase 2 study of Influenza that has completed, run by MedImmune. The registered enrollment target is 31 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00192309, a Phase 2 study of Influenza, has completed, sponsored by MedImmune.

COMPLETED
Registry status
Phase 2
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study was to perform a variety of assays on blood, serum, nasal wash and cell samples obtained from healthy adult subjects for the purposes of developing assays for application in the further investigation of immune responses generated by influenza virus vaccine, trivalent, types A \& B, live, cold-adapted (liquid formulation CAIV-T; Wyeth, Marietta, PA).

Conditions Studied

Influenza

Interventions

  • BIOLOGICAL Placebo
  • BIOLOGICAL TIV
  • BIOLOGICAL CAIV-T

Study Locations (1)

Connecticut

  • David M. Radin, MD - Stamford

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2001-09
Est. Completion 2001-12
Phase Phase 2

Sponsor

MedImmune

210 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00192309

The ClinicalTrials.gov registry entry for NCT00192309 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00192309 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00192309 about?

NCT00192309 is a clinical study titled "Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.". The primary objective of this study was to perform a variety of assays on blood, serum, nasal wash and cell samples obtained from healthy adult subjects for the purposes of developing assays for application in the further investigation of immune responses generated by influenza virus vaccine, trival...

What is the current status of trial NCT00192309?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2001-09. Estimated completion is 2001-12.

What conditions does trial NCT00192309 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT00192309?

The interventions under investigation include: Placebo (BIOLOGICAL), TIV (BIOLOGICAL), CAIV-T (BIOLOGICAL).

Who is sponsoring clinical trial NCT00192309?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00192309 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Influenza

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.